ArticleNagoya journal of medical science2020

Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.

Yoshitaka Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.